Natco Pharma Limited has informed the Exchange about press release dated 17-Aug-2022 titled NATCO announces tentative approval to its ANDA for Trabectedin (generic for Yondelis��)……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
